Egg Medical Gains Patent Advantage After Rampart Appeal Ends
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
ST. PAUL, Minnesota, August 11, 2026 Egg Medical, Inc., a medical technology company focused on radiation protection for healthcare...
WALNUT CREEK, California & SHANGHAI, China, August 11, 2026 Dark Horse Consulting Group (DHCG), a life sciences consulting organization...
San Diego, California, August 5, 2026 NueCell Bio has officially launched as a specialized cell therapy science and development...
CHICAGO, July 30, 2026 EVERSANA has been selected by Innovacell Inc. as its exclusive U.S. commercialization partner to support...
CAMBRIDGE, UK, July 23, 2026 AstraZeneca has secured European Commission approval for Etcamah (camizestrant) in combination with a CDK4/6...
WALTHAM, Mass. & BOTHELL, Wash., July 22, 2026 Repligen Corporation has announced a definitive agreement to acquire BioLife Solutions...
SAN DIEGO, Calif., July 7, 2026 Nucleus Biologics has launched CRAICâ„¢ Formulation Finder, a new large language model (LLM)-powered...
OXFORD, England & STAMFORD, Conn., July 8, 2026 Caristo Diagnostics has announced that new clinical evidence supporting its AI-powered...
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
DALLAS, May 27, 2026 Nanoscope Therapeutics Inc., a biotechnology company developing disease-agnostic therapies for retinal degeneration and vision impairment,...
